Breaking News
Get 50% Off 0
💎 Bargain Hunter: Undervalued stocks with massive upside potential
Get the list
Close

PRISM BioLab Co Ltd (206A)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
177.00 +2.00    +1.14%
07:30:29 - Closed. Currency in JPY
Type:  Equity
Market:  Japan
ISIN:  JP3833190006 
  • Volume: 151,300
  • Bid/Ask: 177.00 / 178.00
  • Day's Range: 175.00 - 180.00
PRISM BioLab 177.00 +2.00 +1.14%

PRISM BioLab Co Ltd Company Profile

 
Get an in-depth profile of PRISM BioLab Co Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

-

Equity Type

ORD

PRISM BioLab Co.,LTD, a biotechnology company, discovers and develops small molecule inhibitors of protein-protein interaction targets utilizing proprietary PepMetics technology for treating patients suffering from cancer, autoimmune, fibrosis, and other diseases. It develops E7386 targeting CBP/beta-catenin, which is in Phase II clinical trial for the treatment of cancer; and PRI724 targeting CBP/beta-catenin that is in Phase II clinical trial for treating cirrhosis. The company has license agreements with Eisai Co., Ltd. and Ohara Pharmaceuticals Co.,Ltd. for the development of drugs for treating cancer and liver diseases. PRISM BioLab Co.,LTD was founded in 2006 and is based in Fujisawa, Japan.

Contact Information

Address 2-26-1, Muraoka-Higashi
Fujisawa, 251-8555
Japan
Phone -
Fax -

Top Executives

Name Age Since Title
Shi Yin Foo - - Member of Scientific Advisory Board
Dai Takehara 61 - Chairman, President & CEO
Dean Rigel - - Member of Scientific Advisory Board
Hiromi Furushima 54 2022 Independent Outside Director
Hiroshi Nagabukuro - - Member of Scientific Advisory Board
Yuji Ishiguro 68 2022 Chairperson of Audit & Supervisory Board
Toshinobu Mamiya 65 2023 Outside Audit & Supervisory Board Member
Teruhisa Tajima 54 2018 Outside Audit & Supervisory Board Member
Kiichiro Kawada 65 2021 Outside Audit & Supervisory Board Member
Hyi-Man Park 56 2022 Director of Research & Development Department and & Director
Shinji Takeuchi 62 - Director of Administrative Department & Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

206A Comments

Write your thoughts about PRISM BioLab Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email